MedPath

Assesment of Embryo Viability and Re-expansion After Thawing in Blastocyst Stage Embryos

Recruiting
Conditions
Infertility
Registration Number
NCT05474833
Lead Sponsor
Akdeniz University
Brief Summary

In this prospective study, the possible effects of embryo viability and degree of blastocele re-expansion on pregnancy outcomes before vitrified/thawed blastocyst transfer will be evaluated.

Detailed Description

Thanks to the advances in embryo vitrification technologies in recent years, high embryo viability can be achieved after thawing, and live birth rates increase after the transfer of these embryos.

Embryo morphology is an essential criterion used to predict embryo viability. Blastocysts endure several morphological challenges during vitrification and thawing, including blastocele collapse, cell collapse, and subsequent rehydration. Blastocysts usually collapse immediately after thawing. Because of these morphological changes, cell damage and loss may occur, and morphological integrity may be impaired.

Considering that implantation results may be affected due to supraphysiological high estrogen and progesterone levels due to multi follicular development in the ovaries during fresh embryo transfers, the study is planned to be conducted only in patients who have undergone artificial endometrial preparation with hormone replacement therapy. Only embryos frozen at the blastocyst stage (day 5) will be included in the study.

After embryo thawing, an experienced embryologist will evaluate embryo viability and expansion and record it in the system. Approximately 2 hours after the indicated procedure (just before embryo transfer), embryo viability and degree of re-expansion will be re-evaluated by the 2nd experienced Embryologist. The evaluation results of both embryologists (embryo viability and re-expansion streams) will be known only to the primary clinician (Assoc. Prof. Şafak Olgan). Pregnancy results will be learned nine days after embryo transfer, In ultrasonography evaluation three weeks after a positive pregnancy result, a clinical pregnancy will be considered in patients with fetal heartbeat, and morphological differences between the pregnant and non-pregnant groups will be evaluated.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
500
Inclusion Criteria
  • Women aged 18-40 years
  • Frozen- thawed embryo transfer cycles
  • Only the cycles prepared artificially with hormone replacement therapy.
  • Embryos with Day 5 (1CC and higher quality)
Exclusion Criteria
  • Embryos at the cleavage stage (D3)
  • Patients for whom embryo viability and expansion were not evaluated single-blindly by two different embryologists

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical pregnancy rateThree weeks after each positive pregnancy test result

In ultrasonography evaluation three weeks after a positive pregnancy result, a clinical pregnancy will be considered in patients with a fetal heartbeat.

Secondary Outcome Measures
NameTimeMethod
Positive β-hCG resultsNine days after each embryo transfer

Positive β-hCG results nine days after embryo transfer.

The effect of re-expansion degrees and viability of embryos on pregnancyThree weeks after each positive pregnancy test result

The correlation between positive pregnancy results and the degree of embryo re-expansion/collapse in transfer after embryo thawing will be determined.

Optimal time between two assessments of expansionAbout 2 hours between thawing and transfer

The optimal expansion assessment time between thaw and embryo transfer will be determined. The evaluation time interval with the best pregnancy rates will be defined as optimal.

Trial Locations

Locations (1)

Akdeniz University

🇹🇷

Antalya, Turkey

© Copyright 2025. All Rights Reserved by MedPath